Insulin and the Blood-Brain Barrier
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
795-800
Author(s):
Stephen C. Woods, Randy J. Seeley, Denis G. Baskin and Michael W. Schwartz
Leptin: From Animals to Humans
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
811-818
Author(s):
Murielle M. Veniant and Carl P. LeBel
Central Amylin Signaling and the Regulation of Energy Homeostasis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
819-825
Author(s):
Paul A. Rushing
Effect of Diabetes on The Blood Brain Barrier
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
833-840
Author(s):
Mohamad H. Horani and Arshag D. Mooradian
Angiotensin-Converting Enzyme Inhibitors: Mechanisms of Action and Implications In Anesthesia Practice
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
763-776
Author(s):
Rahim Behnia, Agostino Molteni and Rajko Igic
Human Tissue Kallikrein: A New Bullet for the Treatment of Ischemia
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
589-597
Author(s):
Costanza Emanueli and Paolo Madeddu
Genetic Polymorphism and Tumor Immunotherapy
Journal:
Current Pharmacogenomics
Volume:
1
Page:
37-57
Author(s):
Rongcun Yang and Richard B.S. Roden
Inhibitors of Protein Tyrosine Phosphatase 1B (PTP1B)
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
759-782
Author(s):
Scott D. Taylor
The Leukocyte Common Antigen-Related Protein LAR: Candidate PTP for Inhibitory Targeting
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
809-819
Author(s):
Charles M. LeVea and Robert A. Mooney
Endothelin-1 and Nitric Oxide in the Pathogenesis of Urinary Tract Disorders Secondary to Bladder Outlet Obstruction
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
27-31
Author(s):
M. A. Khan, C. S. Thompson, M. R. Dashwood, F. H. Mumtaz, R. J. Morgan and D. P. Mikhailidis